Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
stomach cancer
Marketing
Deciphera cracks the door open for off-label cancer drug use
Without a phase 3 trial win, Deciphera is counting on a safety edge to potentially drive off-label use in GIST.
Angus Liu
Jan 25, 2022 12:02pm
Deciphera misses blockbuster opportunity with Qinlock flop
Nov 5, 2021 11:43am
Opdivo-Yervoy flops 2 stomach cancer trials
Sep 19, 2021 9:05am
Enhertu delivers massive progression edge over Kadcyla
Sep 18, 2021 9:05am
Abogen, Lilly-Innovent, XtalPi—Fierce Pharma Asia
Aug 20, 2021 9:30am
Merck yanks Keytruda's FDA nod in third-line stomach cancer
Jul 2, 2021 11:26am
